Home » Authors » Trista Morrison

Articles by Trista Morrison

Sofinnova Closes $375M Fund To Support Spinouts

Nov. 15, 2006

By Trista Morrison

Vasogen Brings In $20.3M To Fund Celacade, VP025 Programs

Nov. 10, 2006

By Trista Morrison

Bradley Licenses U.S. Rights To BioSante's Bio-E-Gel Product

Nov. 9, 2006

By Trista Morrison

Bradley Licenses U.S. Rights To BioSante's Bio-E-Gel Product

Nov. 9, 2006

By Trista Morrison

Celgene Raises $1B As Part Of Addition To S&P 500 Index

Nov. 7, 2006

By Trista Morrison

Celgene Raises $1B As Part Of Addition To S&P 500 Index

Nov. 7, 2006

By Trista Morrison

Exelixis' Stock Falls After XL999 Phase II Suspension

Nov. 3, 2006

By Trista Morrison

Exelixis' Stock Falls After XL999 Phase II Suspension

Nov. 3, 2006

By Trista Morrison

Critical Therapeutics Gets $20M, Bets On Zileuton CR

Nov. 2, 2006

By Trista Morrison

Critical Therapeutics Gets $20M, Bets On Zileuton CR

Nov. 2, 2006

By Trista Morrison

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...